News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Nycomed Deal Shows How Small PE Firms Can Reap Billions



10/4/2012 8:06:53 AM

BIG U.S. PRIVATE EQUITY firms like Carlyle, TPG and Blackstone may have billions more in assets, but Nordic Capital, a relatively small ($7.5 billion in assets) firm based in Stockholm, can claim one of the biggest killings in PE history. Along with New York-based Avista Capital Partners, Nordic Capital turned a $2.6 billion investment in a neglected Norwegian pharmaceutical company into an estimated profit of $10 billion and counting. Nordic first invested in Nycomed in 1999 when it was a “small, regional pharma company that wasn’t actually attractive to any buyers,” says Kristoffer Melinder, a former United Nations officer in Bosnia and JPMorgan banker who joined Nordic in 1998.

Read at Forbes


comments powered by Disqus
Forbes
Nycomed
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES